{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T16:08:49Z","timestamp":1762272529734,"version":"3.40.5"},"reference-count":55,"publisher":"American Academy of Pediatrics (AAP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,3,1]]},"abstract":"<jats:p>Failure of the normal transition from in utero to ex utero physiology leads to \u201cpersistent\u201d pulmonary hypertension of the newborn (PPHN). PPHN is frequently associated with low systemic blood pressure and low cardiac output because of increased right ventricular afterload and myocardial dysfunction. The general management of newborns with PPHN is geared toward maintenance of normothermia, normal serum electrolytes, normal intravascular volume, correction of acidosis, adequate sedation\/analgesia, adequate ventilation and oxygenation with optimal lung recruitment, and avoidance of hyperoxia. Inotropic and vasoactive agents are commonly initiated early to increase cardiac output, maintain adequate systemic blood pressure, and enhance oxygen delivery to the tissue. Unfortunately, there is not much evidence on the choice, timing of initiation, dosing, monitoring, and titrating of vasoactive agents in this patient population. In this review, we will discuss the pathophysiology of PPHN and review the use of inotropic, lusitropic, and vasoactive agents in the management of PPHN, with particular attention to milrinone.<\/jats:p>","DOI":"10.1542\/neo.21-3-e165","type":"journal-article","created":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T14:24:29Z","timestamp":1583159069000},"page":"e165-e178","source":"Crossref","is-referenced-by-count":11,"title":["Milrinone Use in Persistent Pulmonary Hypertension of the Newborn"],"prefix":"10.1542","volume":"21","author":[{"given":"Amna","family":"Qasim","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Division of Pediatric Cardiology, Texas Children\u2019s Hospital\/Baylor College of Medicine, Houston, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil K.","family":"Jain","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Neonatology, University of Texas Medical Branch, Galveston, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2020,3,1]]},"reference":[{"issue":"3","key":"2021121007393078900_B1","doi-asserted-by":"crossref","first-page":"F213","DOI":"10.1136\/adc.2005.071829","article-title":"Which inotrope for which baby?","volume":"91","author":"Evans","year":"2006","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"4","key":"2021121007393078900_B2","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.siny.2015.03.001","article-title":"Persistent pulmonary hypertension of the newborn: advances in diagnosis and treatment","volume":"20","author":"Jain","year":"2015","journal-title":"Semin Fetal Neonatal Med"},{"issue":"5","key":"2021121007393078900_B3","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1161\/01.CIR.94.5.1068","article-title":"Role of the pulmonary circulation in the distribution of human fetal cardiac output during the second half of pregnancy","volume":"94","author":"Rasanen","year":"1996","journal-title":"Circulation"},{"issue":"3","key":"2021121007393078900_B4","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0095-5108(18)30039-3","article-title":"Pulmonary vascular biology during neonatal transition","volume":"26","author":"Lakshminrusimha","year":"1999","journal-title":"Clin Perinatol"},{"issue":"2","key":"2021121007393078900_B5","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1097\/PCC.0b013e3181c76cdc","article-title":"Neonatal pulmonary hypertension","volume":"11","author":"Steinhorn","year":"2010","journal-title":"Pediatr Crit Care Med"},{"key":"2021121007393078900_B6","doi-asserted-by":"crossref","first-page":"194","DOI":"10.7196\/SAJCH.2016.v10i4.1145","article-title":"The management of persistent pulmonary hypertension of the newborn: A review","volume":"10","author":"Lloyd","year":"2016","journal-title":"S African J Child Health."},{"issue":"2","key":"2021121007393078900_B7","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/cvr\/15.2.108","article-title":"Adaptation of the pulmonary circulation to extra-uterine life in the pig and its relevance to the human infant","volume":"15","author":"Haworth","year":"1981","journal-title":"Cardiovasc Res"},{"issue":"5 pt 2","key":"2021121007393078900_B8","first-page":"H1474","article-title":"Effects of birth-related stimuli on L-arginine-dependent pulmonary vasodilation in ovine fetus","volume":"262","author":"Cornfield","year":"1992","journal-title":"Am J Physiol"},{"issue":"3","key":"2021121007393078900_B9","first-page":"L513","article-title":"Inducible NO synthase inhibition attenuates shear stress-induced pulmonary vasodilation in the ovine fetus","volume":"276","author":"Rairigh","year":"1999","journal-title":"Am J Physiol"},{"issue":"4","key":"2021121007393078900_B10","doi-asserted-by":"crossref","first-page":"L727","DOI":"10.1152\/ajplung.00409.2004","article-title":"Effects of BAY 41-2272, a soluble guanylate cyclase activator, on pulmonary vascular reactivity in the ovine fetus","volume":"288","author":"Deruelle","year":"2005","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"3","key":"2021121007393078900_B11","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.athoracsur.2005.09.022","article-title":"Effects of phosphodiesterase 5 inhibitor on pulmonary vascular reactivity in the fetal lamb","volume":"81","author":"Jaillard","year":"2006","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"2021121007393078900_B12","doi-asserted-by":"crossref","first-page":"e272","DOI":"10.1542\/peds.2006-3037","article-title":"Risk factors for persistent pulmonary hypertension of the newborn","volume":"120","author":"Hern\u00e1ndez-D\u00edaz","year":"2007","journal-title":"Pediatrics"},{"issue":"8","key":"2021121007393078900_B13","first-page":"4","article-title":"Persistent pulmonary hypertension in the newborn","volume":"4","author":"Mathew","year":"2017","journal-title":"Children (Basel)"},{"issue":"21","key":"2021121007393078900_B14","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1161\/CIR.0000000000000329","article-title":"Pediatric Pulmonary Hypertension: Guidelines From the American Heart Association and American Thoracic Society","volume":"132","author":"Abman","year":"2015","journal-title":"Circulation"},{"issue":"4","key":"2021121007393078900_B15","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1651-2227.2011.02572.x","article-title":"Global myocardial function is compromised in infants with pulmonary hypertension","volume":"101","author":"Sehgal","year":"2012","journal-title":"Acta Paediatr"},{"issue":"2","key":"2021121007393078900_B16","doi-asserted-by":"crossref","first-page":"e414","DOI":"10.1542\/peds.2010-3428","article-title":"Inhaled nitric oxide in preterm infants: a systematic review","volume":"127","author":"Donohue","year":"2011","journal-title":"Pediatrics"},{"issue":"4","key":"2021121007393078900_B17","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.siny.2017.03.004","article-title":"Persistent pulmonary hypertension of the newborn","volume":"22","author":"Fuloria","year":"2017","journal-title":"Semin Fetal Neonatal Med"},{"issue":"6","key":"2021121007393078900_B18","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/sj.jp.7210761","article-title":"Inhaled nitric oxide and gentle ventilation in the treatment of pulmonary hypertension of the newborn: a single-center, 5-year experience","volume":"22","author":"Gupta","year":"2002","journal-title":"J Perinatol"},{"issue":"3","key":"2021121007393078900_B19","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1891\/0730-0832.36.3.160","article-title":"Treatment of persistent pulmonary hypertension of the newborn: use of pulmonary vasodilators in term neonates","volume":"36","author":"Luecke","year":"2017","journal-title":"Neonatal Netw"},{"issue":"4 Pt 1","key":"2021121007393078900_B20","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1542\/peds.98.4.706","article-title":"Four patterns of response to inhaled nitric oxide for persistent pulmonary hypertension of the newborn","volume":"98","author":"Goldman","year":"1996","journal-title":"Pediatrics"},{"issue":"11","key":"2021121007393078900_B21","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/j.1651-2227.1995.tb13558.x","article-title":"Methaemoglobinaemia with high-dose nitric oxide administration","volume":"84","author":"Heal","year":"1995","journal-title":"Acta Paediatr"},{"issue":"4","key":"2021121007393078900_B22","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1161\/hh1601.094983","article-title":"Role for endothelin-1-induced superoxide and peroxynitrite production in rebound pulmonary hypertension associated with inhaled nitric oxide therapy","volume":"89","author":"Wedgwood","year":"2001","journal-title":"Circ Res"},{"key":"2021121007393078900_B23","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1038\/jp.2016.44","article-title":"Considerations in the management of hypoxemic respiratory failure and persistent pulmonary hypertension in term and late preterm neonates","volume":"36","author":"Lakshminrusimha","year":"2016","journal-title":"J Perinatol"},{"issue":"2","key":"2021121007393078900_B24","doi-asserted-by":"crossref","first-page":"R607","DOI":"10.1152\/ajpregu.2001.281.2.R607","article-title":"Effects of catecholamines on the pulmonary circulation in the ovine fetus","volume":"281","author":"Jaillard","year":"2001","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"3","key":"2021121007393078900_B25","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/cc1016","article-title":"The effects of dopamine and epinephrine on hemodynamics and oxygen metabolism in hypoxic anesthetized piglets","volume":"5","author":"Cheung","year":"2001","journal-title":"Crit Care"},{"issue":"2","key":"2021121007393078900_B26","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s00246-008-9303-3","article-title":"Correlation of echocardiographic markers and therapy in persistent pulmonary hypertension of the newborn","volume":"30","author":"Peterson","year":"2009","journal-title":"Pediatr Cardiol"},{"issue":"4","key":"2021121007393078900_B27","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1097\/00003246-199504000-00024","article-title":"A blind, randomized comparison of the circulatory effects of dopamine and epinephrine infusions in the newborn piglet during normoxia and hypoxia","volume":"23","author":"Barrington","year":"1995","journal-title":"Crit Care Med"},{"issue":"2","key":"2021121007393078900_B28","doi-asserted-by":"crossref","first-page":"F105","DOI":"10.1136\/fn.78.2.F105","article-title":"Range of echocardiographic findings in term neonates with high oxygen requirements","volume":"78","author":"Evans","year":"1998","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"4","key":"2021121007393078900_B29","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/sj.jp.7210908","article-title":"Low-dose nitric oxide therapy for persistent pulmonary hypertension: 1-year follow-up","volume":"23","author":"Clark","year":"2003","journal-title":"J Perinatol"},{"issue":"2","key":"2021121007393078900_B30","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/j.jpedsurg.2010.10.006","article-title":"Terlipressin as rescue therapy for refractory pulmonary hypertension in a neonate with a congenital diaphragmatic hernia","volume":"46","author":"Stathopoulos","year":"2011","journal-title":"J Pediatr Surg"},{"issue":"3","key":"2021121007393078900_B31","first-page":"1650","article-title":"Phosphodiesterase inhibition improves agonist-induced relaxation of hypertensive pulmonary arteries","volume":"282","author":"Wagner","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"2021121007393078900_B32","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1067\/mpd.2002.123100","article-title":"Dopamine effects on pulmonary artery pressure in hypotensive preterm infants with patent ductus arteriosus","volume":"140","author":"Liet","year":"2002","journal-title":"J Pediatr"},{"issue":"6","key":"2021121007393078900_B33","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/bja\/aeh278","article-title":"Pulmonary vasodilator effects of norepinephrine during the development of chronic pulmonary hypertension in neonatal lambs","volume":"93","author":"Jaillard","year":"2004","journal-title":"Br J Anaesth"},{"issue":"3","key":"2021121007393078900_B34","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jpeds.2008.03.007","article-title":"Pulmonary circulatory effects of norepinephrine in newborn infants with persistent pulmonary hypertension","volume":"153","author":"Tourneux","year":"2008","journal-title":"J Pediatr"},{"issue":"2","key":"2021121007393078900_B35","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/PCC.0b013e31829f5fce","article-title":"Vasopressin as a rescue therapy for refractory pulmonary hypertension in neonates: case series","volume":"15","author":"Mohamed","year":"2014","journal-title":"Pediatr Crit Care Med"},{"issue":"11","key":"2021121007393078900_B36","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1097\/00003246-199511000-00018","article-title":"Milrinone: systemic and pulmonary hemodynamic effects in neonates after cardiac surgery","volume":"23","author":"Chang","year":"1995","journal-title":"Crit Care Med"},{"issue":"3","key":"2021121007393078900_B37","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/00003246-200003000-00031","article-title":"Additive effects of inhaled nitric oxide and intravenous milrinone in experimental pulmonary hypertension","volume":"28","author":"Deb","year":"2000","journal-title":"Crit Care Med"},{"issue":"1","key":"2021121007393078900_B38","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/PCC.0b013e3181936aee","article-title":"Milrinone enhances relaxation to prostacyclin and iloprost in pulmonary arteries isolated from lambs with persistent pulmonary hypertension of the newborn","volume":"10","author":"Lakshminrusimha","year":"2009","journal-title":"Pediatr Crit Care Med"},{"issue":"35","key":"2021121007393078900_B39","doi-asserted-by":"crossref","first-page":"26286","DOI":"10.1016\/S0021-9258(19)74313-0","article-title":"Nitric oxide regulates cardiac Ca2+ current. Involvement of cGMP-inhibited and cGMP-stimulated phosphodiesterases through guanylyl cyclase activation","volume":"268","author":"M\u00e9ry","year":"1993","journal-title":"J Biol Chem"},{"issue":"3 Pt 2","key":"2021121007393078900_B40","first-page":"III46","article-title":"The inotropic effects of amrinone and milrinone on neonatal and young canine cardiac muscle","volume":"73","author":"Binah","year":"1986","journal-title":"Circulation"},{"issue":"2 Pt 2","key":"2021121007393078900_B41","first-page":"H335","article-title":"Inotropic responses change during postnatal maturation in rabbit","volume":"255","author":"Artman","year":"1988","journal-title":"Am J Physiol"},{"issue":"7","key":"2021121007393078900_B42","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1161\/01.CIR.0000051365.81920.28","article-title":"Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease","volume":"107","author":"Hoffman","year":"2003","journal-title":"Circulation"},{"key":"2021121007393078900_B43","first-page":"3","article-title":"A population pharmacokinetic analysis of milrinone in pediatric patients after cardiac surgery","volume-title":"J Pharmacokinet Pharmacodyn.","author":"Bailey","year":"2004"},{"issue":"1","key":"2021121007393078900_B44","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.clp.2011.12.010","article-title":"Neonatal blood pressure support: the use of inotropes, lusitropes, and other vasopressor agents","volume":"39","author":"Noori","year":"2012","journal-title":"Clin Perinatol"},{"issue":"3","key":"2021121007393078900_B45","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jpeds.2005.11.030","article-title":"Pilot study of milrinone for low systemic blood flow in very preterm infants","volume":"148","author":"Paradisis","year":"2006","journal-title":"J Pediatr"},{"issue":"3","key":"2021121007393078900_B46","doi-asserted-by":"crossref","first-page":"F204","DOI":"10.1136\/adc.2005.092817","article-title":"Population pharmacokinetics and dosing regimen design of milrinone in preterm infants","volume":"92","author":"Paradisis","year":"2007","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"2","key":"2021121007393078900_B47","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000339108","article-title":"Use of milrinone to treat cardiac dysfunction in infants with pulmonary hypertension secondary to congenital diaphragmatic hernia: a review of six patients","volume":"102","author":"Patel","year":"2012","journal-title":"Neonatology"},{"issue":"11","key":"2021121007393078900_B48","doi-asserted-by":"crossref","first-page":"e006809","DOI":"10.1161\/CIRCIMAGING.117.006809","article-title":"Mother with diabetes mellitus and infant with hypertrophic obstructive cardiomyopathy: milrinone precluded need for extracorporeal membrane oxygenation","volume":"10","author":"Dasgupta","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"issue":"1","key":"2021121007393078900_B49","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1017\/S1047951114002698","article-title":"The effect of milrinone on right and left ventricular function when used as a rescue therapy for term infants with pulmonary hypertension","volume":"26","author":"James","year":"2016","journal-title":"Cardiol Young"},{"issue":"2","key":"2021121007393078900_B50","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1213\/00000539-199802000-00011","article-title":"Pharmacokinetics and side effects of milrinone in infants and children after open heart surgery","volume":"86","author":"Ramamoorthy","year":"1998","journal-title":"Anesth Analg"},{"issue":"1","key":"2021121007393078900_B51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000088192","article-title":"Neonatal persistent pulmonary hypertension treated with milrinone: four case reports","volume":"89","author":"Bassler","year":"2006","journal-title":"Biol Neonate"},{"issue":"1","key":"2021121007393078900_B52","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/PCC.0b013e31824ea2cd","article-title":"Pharmacology of milrinone in neonates with persistent pulmonary hypertension of the newborn and suboptimal response to inhaled nitric oxide","volume":"14","author":"McNamara","year":"2013","journal-title":"Pediatr Crit Care Med"},{"issue":"8","key":"2021121007393078900_B53","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1055\/s-0036-1597996","article-title":"Milrinone pharmacokinetics and pharmacodynamics in neonates with persistent pulmonary hypertension of the newborn","volume":"34","author":"Giaccone","year":"2017","journal-title":"Am J Perinatol"},{"key":"2021121007393078900_B54","first-page":"173C","article-title":"Inhaled milrinone for pulmonary hypertension in cardiac surgery: a prospective randomized study","volume":"23","author":"Denault","year":"2007","journal-title":"Can J Cardiol"},{"issue":"2","key":"2021121007393078900_B55","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jcrc.2006.01.001","article-title":"Milrinone improves oxygenation in neonates with severe persistent pulmonary hypertension of the newborn","volume":"21","author":"McNamara","year":"2006","journal-title":"J Crit Care"}],"container-title":["NeoReviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/neoreviews\/article-pdf\/21\/3\/e165\/822038\/neoreviews_072019cmerev00099.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/neoreviews\/article-pdf\/21\/3\/e165\/822038\/neoreviews_072019cmerev00099.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T19:10:54Z","timestamp":1639163454000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/neoreviews\/article\/21\/3\/e165\/92225\/Milrinone-Use-in-Persistent-Pulmonary-Hypertension"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,1]]},"references-count":55,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,3,1]]},"published-print":{"date-parts":[[2020,3,1]]}},"URL":"https:\/\/doi.org\/10.1542\/neo.21-3-e165","relation":{},"ISSN":["1526-9906"],"issn-type":[{"type":"electronic","value":"1526-9906"}],"subject":[],"published":{"date-parts":[[2020,3,1]]}}}